JEMEGZI Trademark

Trademark Overview

On Monday, August 2, 2021, a trademark application was filed for JEMEGZI with the United States Patent and Trademark Office. The USPTO has given the JEMEGZI trademark a serial number of 90860810. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 11, 2025. This trademark is owned by Celgene Corporation. The JEMEGZI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for oncology
jemegzi

General Information

Serial Number90860810
Word MarkJEMEGZI
Filing DateMonday, August 2, 2021
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 11, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 10, 2022

Trademark Statements

Goods and ServicesPharmaceutical preparations for oncology

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, September 28, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCelgene Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901
Party NameCelgene Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901

Trademark Events

Event DateEvent Description
Thursday, January 27, 2022NON-FINAL ACTION WRITTEN
Thursday, August 5, 2021NEW APPLICATION ENTERED
Tuesday, September 28, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, January 24, 2022ASSIGNED TO EXAMINER
Thursday, January 27, 2022NON-FINAL ACTION E-MAILED
Thursday, January 27, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, March 31, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, March 31, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, April 1, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, April 4, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 20, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 10, 2022PUBLISHED FOR OPPOSITION
Tuesday, May 10, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 5, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, January 4, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, January 4, 2023SOU EXTENSION 1 FILED
Wednesday, January 4, 2023SOU EXTENSION 1 GRANTED
Friday, January 6, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 28, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, June 28, 2023SOU EXTENSION 2 FILED
Wednesday, June 28, 2023SOU EXTENSION 2 GRANTED
Friday, June 30, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 2, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, January 2, 2024SOU EXTENSION 3 FILED
Tuesday, January 2, 2024SOU EXTENSION 3 GRANTED
Thursday, January 4, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 18, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, June 18, 2024SOU EXTENSION 4 GRANTED
Tuesday, June 18, 2024SOU EXTENSION 4 FILED
Wednesday, December 11, 2024SOU EXTENSION 5 FILED
Wednesday, December 11, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, June 18, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 27, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, April 2, 2025SOU EXTENSION 5 GRANTED
Monday, August 11, 2025ABANDONMENT - NO USE STATEMENT FILED
Monday, August 11, 2025ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Thursday, April 3, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

jemegzi oncology preparations pharmaceutical